Dual CVD risk tools 'confusing'

GPs have warned that including both the QRISK2 and Framingham risk scores in guidelines for the vascular checks programme will create confusion.

Professor Roger Boyle, England's national director for heart disease and stroke, told GP that both options would be covered in standard operating procedures. He said data on both were being considered by NICE.

But Dr Terry McCormack, former chairman of the Primary Care Cardiovascular Society, said multiple risk tools would cause confusion and urged the DoH to 'pick one'.

Berkshire GP Dr George Kassianos, a member of the British Cardiology Society, added that neither tool was satisfactory. 'In the absence of a good and proven UK-wide risk tool, I would recommend we stay with Framingham,' he said.

QRISK2 is now widely used, however. Professor Boyle said: 'The majority of PCTs we have had contact with, and practices, are actually looking toward QRISK2 because it includes deprivation as a risk factor and ethnicity.'

The DoH guidelines for vascular screening were due for publication as GP went to press.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in